Clinical Trial Detail

NCT ID NCT02257138
Title Study of Ruxolitinib Plus Decitabine in Patients With Acute Myeloid Leukemia (AML)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Decitabine + Ruxolitinib

Age Groups: adult

No variant requirements are available.